24 February 2021>: Clinical Research
Expression of Cell Division Cycle Protein 45 in Tissue Microarrays and the Gene by Bioinformatics Analysis in Human Hepatocellular Carcinoma and Patient Outcomes
Hui-Ping Lu 1ABCDEFG , Xiu-Fang Du 1BCDEF , Jian-Di Li 1BCDEF , Su-Ning Huang 2ADEF , Rong-Quan He 3ABDEF , Hua-Yu Wu 4ABDEF , Ming-Fen Li 5BCDEF , Wei-Zi Wu 6CDEF , Ji-Tian Chen 6BCDE , Wei-Jia Mo 1ABCDEFG , Gang Chen 1ABCDEFG*DOI: 10.12659/MSM.928800
Med Sci Monit 2021; 27:e928800
Figure 7 The clinical implications of CDC45 genetic alterations. (A) The oncoprint of CDC45 in 360 patients/complete samples from 442 cases of hepatocellular carcinoma (HCC). CDC45 was altered in 34 (9%) cases. Patients with the CDC45 genetic alteration were more likely to have poor lifespan (B, for overall survival; C, for disease-free survival).